Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Engineered antibodies.

× No keyword cloud information.

97 in total

1. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.

Authors: Hee-Joo Kim; Mark R McCoy; Zuzana Majkova; Julie E Dechant; Shirley J Gee; Sofia Tabares-da Rosa; Gualberto G González-Sapienza; Bruce D Hammock
Journal: Anal Chem Date: 2011-12-29 Impact factor: 6.986

Review 2. Molecular targeting of angiogenesis for imaging and therapy.

Authors: Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal: Eur J Nucl Med Mol Imaging Date: 2004-08-05 Impact factor: 9.236

Review 3. Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors: Frédéric Ducancel; Bruno H Muller
Journal: MAbs Date: 2012-07-01 Impact factor: 5.857

4. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Authors: Xiaoling Wang; Satish K Singh; Sandeep Kumar
Journal: Pharm Res Date: 2010-04-27 Impact factor: 4.200

Review 5. Metrics for antibody therapeutics development.

Authors: Janice M Reichert
Journal: MAbs Date: 2010-11-01 Impact factor: 5.857

6. Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin.

Authors: Lidia Riaño-Umbarila; Luis M Ledezma-Candanoza; Hugo Serrano-Posada; Guillermo Fernández-Taboada; Timoteo Olamendi-Portugal; Sonia Rojas-Trejo; Ilse V Gómez-Ramírez; Enrique Rudiño-Piñera; Lourival D Possani; Baltazar Becerril
Journal: J Biol Chem Date: 2015-11-20 Impact factor: 5.157

Engineered antibodies.

1. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.

Review 2. Molecular targeting of angiogenesis for imaging and therapy.

Review 3. Molecular engineering of antibodies for therapeutic and diagnostic purposes.

4. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Review 5. Metrics for antibody therapeutics development.

6. Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin.

Review 7. Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Review 8. A new generation of protein display scaffolds for molecular recognition.

Review 9. Ligand-targeted delivery of therapeutic siRNA.

10. Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use.